Industry Research Reports

Home > Reports > Chemical & Material > Global Pharmaceutical Activated Carbon Industry Research Report, Growth Trends and Competitive Analysis 2024-2030

Global Pharmaceutical Activated Carbon Industry Research Report, Growth Trends and Competitive Analysis 2024-2030

Industry: Chemical & Material

Published Date: 2024-04-17

Pages: 147 Pages

Report ld: 2706388

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Pharmaceutical Activated Carbon market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Activated charcoal has been used as an oral medicine for a long time, and in the rescue and treatment of patients with acute transoral poisoning, medicinal activated charcoal is one of the important basic rescue measures, which can obviously reduce the absorption of poison and increase the excretion and removal of poison, and obviously improve the success rate of rescue of patients with transoral poisoning. Oral administration of activated carbon is an effective method to reduce the absorption of poisons taken by patients. As an excellent adsorbent material, activated carbon is not only used for oral adsorption and detoxification in emergency medicine, but also widely used as a blood perfusion adsorbent for artificial organ adsorption preparations, for specific central nervous system, for treating certain previously incurable diseases, and in recent years it has also been used as a drug carrier for solutes, for treating malignant tumors Lymph nodes, for guiding the removal of metastatic lymph nodes, and for adjust the pore size of activated carbon and its distribution so that it can absorb various harmful substances and bacteria.

Units: The units in this report refer to the basic quantity units of statistics, such as tablets (Changtian Pharmaceuticals) for the tablet type, and capsules and pills for the pill type, such as Wuxi Ji Yu Shanhe Pharmaceuticals. The unit of product for bag type or granule type is bag.

The key manufacturers of pharmaceutical activated carbon in the Chinese market are Jemincare, Changtian Pharma, Kureha, Myvitamins, etc. The top two manufacturers account for 99% of the market share, with the largest manufacturer being Jemincare with 89%. Production areas are mainly located in Europe, China, Japan, etc. In terms of product type, activated carbon tablets/granules occupy the major market share, accounting for 90%, followed by activated carbon capsules, accounting for about 10%. In terms of application, the pharmacy channel is the top application area, accounting for 70% of the total, while the prescription channel accounts for 28%.

In terms of production side, this report researches the Pharmaceutical Activated Carbon capacity, production, growth rate, market share by manufacturers, region level and country level, from 2019 to 2024, and forecast to 2030.

In terms of sales (consumption) side, this report focuses on the sales of Pharmaceutical Activated Carbon by region (Countries), company, type and distribution channel. from 2019 to 2024 and forecast to 2030.

The global Pharmaceutical Activated Carbon market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by type segment of the global Pharmaceutical Activated Carbon market. These figures have been provided in terms of both revenue and volume for the period 2019-2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

MARKET SEGMENTATION

By Company

Jemincare
Changtian Pharma
Kureha
Myvitamins

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Pharmaceutical Activated Carbon Capsule
Pharmaceutical Activated Carbon Tablet
Others

Segment by Application

Drug Stores
Prescription Drug

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by distribution channel, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Pharmaceutical Activated Carbon in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Pharmaceutical Activated Carbon production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Detailed analysis of Pharmaceutical Activated Carbon manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by distribution channel, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by company, by type, by distribution channel and by country, sales, and revenue for each segment.

Chapter 8: Europe by company, by type, by distribution channel and by country, sales, and revenue for each segment.

Chapter 9: China by company, by type and by distribution channel, sales, and revenue for each segment.

Chapter 10: APAC (excluding China) by company, by type, by distribution channel and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, and Latin America by company, by type, by distribution channel and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Activated Carbon sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Pharmaceutical Activated Carbon Definition

1.2 Market by Type

1.2.1 Global Pharmaceutical Activated Carbon Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Pharmaceutical Activated Carbon Capsule

1.2.3 Pharmaceutical Activated Carbon Tablet

1.2.4 Others

1.3 Market by Distribution Channel

1.3.1 Global Pharmaceutical Activated Carbon Market Size Growth Rate by Distribution Channel, 2019 VS 2023 VS 2030

1.3.2 Drug Stores

1.3.3 Prescription Drug

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Pharmaceutical Activated Carbon Sales

2.1 Global Pharmaceutical Activated Carbon Revenue Estimates and Forecasts 2019-2030

2.2 Global Pharmaceutical Activated Carbon Revenue by Region: 2019 VS 2023 VS 2030

2.3 Global Pharmaceutical Activated Carbon Revenue by Region

2.3.1 Global Pharmaceutical Activated Carbon Revenue by Region (2019-2024)

2.3.2 Global Pharmaceutical Activated Carbon Revenue by Region (2025-2030)

2.4 Global Pharmaceutical Activated Carbon Sales Quantity Estimates and Forecasts 2019-2030

2.5 Global Pharmaceutical Activated Carbon Sales Quantity by Region: 2019 VS 2023 VS 2030

2.6 Global Pharmaceutical Activated Carbon Sales Quantity by Region

2.6.1 Global Pharmaceutical Activated Carbon Sales Quantity by Region (2019-2024)

2.6.2 Global Pharmaceutical Activated Carbon Sales Quantity by Region (2025-2030)

2.7 North America

2.8 Europe

2.9 China

2.10 APAC (excluding China)

2.11 Middle East, Africa and Latin America

3 Global Production (Based on Production Site)

3.1 Global Pharmaceutical Activated Carbon Production Value by Region: 2019 VS 2023 VS 2030

3.2 Global Pharmaceutical Activated Carbon Production Value by Region

3.2.1 Global Pharmaceutical Activated Carbon Historic Production Value by Region (2019-2024)

3.2.2 Global Pharmaceutical Activated Carbon Forecasted Production Value by Region (2025-2030)

3.3 Global Pharmaceutical Activated Carbon Production Capacity (2019-2030)

3.4 Global Pharmaceutical Activated Carbon Production by Region: 2019 VS 2023 VS 2030

3.5 Global Pharmaceutical Activated Carbon Production by Region

3.5.1 Global Pharmaceutical Activated Carbon Historic Production by Region (2019-2024)

3.5.2 Global Pharmaceutical Activated Carbon Forecasted Production by Region (2025-2030)

3.5.3 North America

3.5.4 Europe

3.5.5 Japan

3.5.6 China

3.5.7 South Korea

3.5.8 India

4 Competition by Manufacturers

4.1 Global Pharmaceutical Activated Carbon Sales Quantity by Manufacturers

4.1.1 Global Pharmaceutical Activated Carbon Sales Quantity by Manufacturers (2019-2024)

4.1.2 Global Pharmaceutical Activated Carbon Sales Quantity Share by Manufacturers (2019-2024)

4.1.3 Global Top 10 and Top 5 Companies by Pharmaceutical Activated Carbon Sales in 2023

4.2 Global Pharmaceutical Activated Carbon Revenue by Manufacturers

4.2.1 Global Pharmaceutical Activated Carbon Revenue by Manufacturers (2019-2024)

4.2.2 Global Pharmaceutical Activated Carbon Revenue Share by Manufacturers (2019-2024)

4.2.3 Global Top 10 and Top 5 Companies by Pharmaceutical Activated Carbon Revenue in 2023

4.3 Global Pharmaceutical Activated Carbon Sales Price by Manufacturers

4.4 Global Key Players of Pharmaceutical Activated Carbon, Industry Ranking, 2022 VS 2023

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global Pharmaceutical Activated Carbon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.6 Global Key Manufacturers of Pharmaceutical Activated Carbon, Manufacturing Base Distribution and Headquarters

4.7 Global Key Manufacturers of Pharmaceutical Activated Carbon, Product Offered and Application

4.8 Global Key Manufacturers of Pharmaceutical Activated Carbon, Date of Enter into This Industry

4.9 Mergers & Acquisitions, Expansion Plans

5 Estimates and Forecasts by Type

5.1 Global Pharmaceutical Activated Carbon Sales Quantity by Type

5.1.1 Global Pharmaceutical Activated Carbon Historical Sales Quantity by Type (2019-2024)

5.1.2 Global Pharmaceutical Activated Carbon Forecasted Sales Quantity by Type (2025-2030)

5.1.3 Global Pharmaceutical Activated Carbon Sales Quantity Market Share by Type (2019-2030)

5.2 Global Pharmaceutical Activated Carbon Revenue by Type

5.2.1 Global Pharmaceutical Activated Carbon Historical Revenue by Type (2019-2024)

5.2.2 Global Pharmaceutical Activated Carbon Forecasted Revenue by Type (2025-2030)

5.2.3 Global Pharmaceutical Activated Carbon Revenue Market Share by Type (2019-2030)

5.3 Global Pharmaceutical Activated Carbon Price by Type

5.3.1 Global Pharmaceutical Activated Carbon Price by Type (2019-2024)

5.3.2 Global Pharmaceutical Activated Carbon Price Forecast by Type (2025-2030)

6 Market Size by Distribution Channel

6.1 Global Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel

6.1.1 Global Pharmaceutical Activated Carbon Historical Sales Quantity by Distribution Channel (2019-2024)

6.1.2 Global Pharmaceutical Activated Carbon Forecasted Sales Quantity by Distribution Channel (2025-2030)

6.1.3 Global Pharmaceutical Activated Carbon Sales Quantity Market Share by Distribution Channel (2019-2030)

6.2 Global Pharmaceutical Activated Carbon Revenue by Distribution Channel

6.2.1 Global Pharmaceutical Activated Carbon Historical Revenue by Distribution Channel (2019-2024)

6.2.2 Global Pharmaceutical Activated Carbon Forecasted Revenue by Distribution Channel (2025-2030)

6.2.3 Global Pharmaceutical Activated Carbon Revenue Market Share by Distribution Channel (2019-2030)

6.3 Global Pharmaceutical Activated Carbon Price by Distribution Channel

6.3.1 Global Pharmaceutical Activated Carbon Price by Distribution Channel (2019-2024)

6.3.2 Global Pharmaceutical Activated Carbon Price Forecast by Distribution Channel (2025-2030)

7 North America

7.1 North America Pharmaceutical Activated Carbon Sales by Company

7.1.1 North America Pharmaceutical Activated Carbon Revenue by Company (2019-2024)

7.1.2 North America Pharmaceutical Activated Carbon Sales Quantity by Company (2019-2024)

7.2 North America Pharmaceutical Activated Carbon Market Size by Type

7.2.1 North America Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2030)

7.2.2 North America Pharmaceutical Activated Carbon Revenue by Type (2019-2030)

7.3 North America Pharmaceutical Activated Carbon Market Size by Distribution Channel

7.3.1 North America Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2030)

7.3.2 North America Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2030)

7.4 North America Pharmaceutical Activated Carbon Market Size by Country

7.4.1 North America Pharmaceutical Activated Carbon Revenue by Country: 2019 VS 2023 VS 2030

7.4.2 North America Pharmaceutical Activated Carbon Revenue by Country (2019-2030)

7.4.3 North America Pharmaceutical Activated Carbon Sales Quantity by Country (2019-2030)

7.4.4 United States

7.4.5 Canada

8 Europe

8.1 Europe Pharmaceutical Activated Carbon Sales by Company

8.1.1 Europe Pharmaceutical Activated Carbon Sales Quantity by Company (2019-2024)

8.1.2 Europe Pharmaceutical Activated Carbon Revenue by Company (2019-2024)

8.2 Europe Pharmaceutical Activated Carbon Market Size by Type

8.2.1 Europe Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2030)

8.2.2 Europe Pharmaceutical Activated Carbon Revenue by Type (2019-2030)

8.3 Europe Pharmaceutical Activated Carbon Market Size by Distribution Channel

8.3.1 Europe Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2030)

8.3.2 Europe Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2030)

8.4 Europe Pharmaceutical Activated Carbon Market Size by Country

8.4.1 Europe Pharmaceutical Activated Carbon Revenue by Country: 2019 VS 2023 VS 2030

8.4.2 Europe Pharmaceutical Activated Carbon Revenue by Country (2019-2030)

8.4.3 Europe Pharmaceutical Activated Carbon Sales Quantity by Country (2019-2030)

8.4.4 Germany

8.4.5 France

8.4.6 U.K.

8.4.7 Italy

8.4.8 Russia

9 China

9.1 China Pharmaceutical Activated Carbon Sales by Company

9.1.1 China Pharmaceutical Activated Carbon Sales Quantity by Company (2019-2024)

9.1.2 China Pharmaceutical Activated Carbon Revenue by Company (2019-2024)

9.2 China Pharmaceutical Activated Carbon Market Size by Type

9.2.1 China Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2030)

9.2.2 China Pharmaceutical Activated Carbon Revenue by Type (2019-2030)

9.3 China Pharmaceutical Activated Carbon Market Size by Distribution Channel

9.3.1 China Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2030)

9.3.2 China Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2030)

10 APAC (excluding China)

10.1 APAC Pharmaceutical Activated Carbon Sales by Company

10.1.1 APAC Pharmaceutical Activated Carbon Sales Quantity by Company (2019-2024)

10.1.2 APAC Pharmaceutical Activated Carbon Revenue by Company (2019-2024)

10.2 APAC Pharmaceutical Activated Carbon Market Size by Type

10.2.1 APAC Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2030)

10.2.2 APAC Pharmaceutical Activated Carbon Revenue by Type (2019-2030)

10.3 APAC Pharmaceutical Activated Carbon Market Size by Distribution Channel

10.3.1 APAC Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2030)

10.3.2 APAC Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2030)

10.4 APAC Pharmaceutical Activated Carbon Market Size by Region

10.4.1 APAC Pharmaceutical Activated Carbon Revenue by Region: 2019 VS 2023 VS 2030

10.4.2 APAC Pharmaceutical Activated Carbon Revenue by Region (2019-2030)

10.4.3 APAC Pharmaceutical Activated Carbon Sales Quantity by Region (2019-2030)

10.4.4 Japan

10.4.5 South Korea

10.4.6 China Taiwan

10.4.7 Southeast Asia

10.4.8 India

11 Middle East, Africa and Latin America

11.1 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales by Company

11.1.1 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Company (2019-2024)

11.1.2 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Company (2019-2024)

11.2 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Market Size by Type

11.2.1 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2030)

11.2.2 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Type (2019-2030)

11.3 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Market Size by Distribution Channel

11.3.1 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2030)

11.3.2 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2030)

11.4 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Market Size by Country

11.4.1 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Country: 2019 VS 2023 VS 2030

11.4.2 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Country (2019-2030)

11.4.3 Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Country (2019-2030)

11.4.4 Brazil

11.4.5 Mexico

11.4.6 Turkey

11.4.7 Israel

11.4.8 GCC Countries

12 Company Profiles

12.1 Jemincare

12.1.1 Jemincare Company Information

12.1.2 Jemincare Overview

12.1.3 Jemincare Pharmaceutical Activated Carbon Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.1.4 Jemincare Pharmaceutical Activated Carbon Products and Services

12.1.5 Jemincare Pharmaceutical Activated Carbon SWOT Analysis

12.1.6 Jemincare Recent Developments

12.2 Changtian Pharma

12.2.1 Changtian Pharma Company Information

12.2.2 Changtian Pharma Overview

12.2.3 Changtian Pharma Pharmaceutical Activated Carbon Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.2.4 Changtian Pharma Pharmaceutical Activated Carbon Products and Services

12.2.5 Changtian Pharma Pharmaceutical Activated Carbon SWOT Analysis

12.2.6 Changtian Pharma Recent Developments

12.3 Kureha

12.3.1 Kureha Company Information

12.3.2 Kureha Overview

12.3.3 Kureha Pharmaceutical Activated Carbon Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.3.4 Kureha Pharmaceutical Activated Carbon Products and Services

12.3.5 Kureha Pharmaceutical Activated Carbon SWOT Analysis

12.3.6 Kureha Recent Developments

12.4 Myvitamins

12.4.1 Myvitamins Company Information

12.4.2 Myvitamins Overview

12.4.3 Myvitamins Pharmaceutical Activated Carbon Sales Quantity, Revenue, Price and Gross Margin (2019-2024)

12.4.4 Myvitamins Pharmaceutical Activated Carbon Products and Services

12.4.5 Myvitamins Pharmaceutical Activated Carbon SWOT Analysis

12.4.6 Myvitamins Recent Developments

13 Value Chain and Sales Channels Analysis

13.1 Pharmaceutical Activated Carbon Value Chain Analysis

13.2 Pharmaceutical Activated Carbon Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 Pharmaceutical Activated Carbon Production Mode & Process

13.4 Pharmaceutical Activated Carbon Sales and Marketing

13.4.1 Pharmaceutical Activated Carbon Sales Channels

13.4.2 Pharmaceutical Activated Carbon Distributors

13.5 Pharmaceutical Activated Carbon Customers

14 Market Dynamics

14.1 Pharmaceutical Activated Carbon Industry Trends

14.2 Pharmaceutical Activated Carbon Market Drivers

14.3 Pharmaceutical Activated Carbon Market Challenges

14.4 Pharmaceutical Activated Carbon Market Restraints

15 Key Findings

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Pharmaceutical Activated Carbon Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Pharmaceutical Activated Carbon Capsule

Table 3. Major Manufacturers of Pharmaceutical Activated Carbon Tablet

Table 4. Major Manufacturers of Others

Table 5. Global Pharmaceutical Activated Carbon Market Size Growth Rate (CAGR) by Distribution Channel, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Pharmaceutical Activated Carbon Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Pharmaceutical Activated Carbon Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Pharmaceutical Activated Carbon Revenue Market Share by Region (2019-2024)

Table 9. Global Pharmaceutical Activated Carbon Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Pharmaceutical Activated Carbon Revenue Market Share by Region (2025-2030)

Table 11. Global Pharmaceutical Activated Carbon Sales Quantity by Region: 2019 VS 2023 VS 2030 (M Units)

Table 12. Global Pharmaceutical Activated Carbon Sales by Region (2019-2024) & (M Units)

Table 13. Global Pharmaceutical Activated Carbon Sales Market Share by Region (2019-2024)

Table 14. Global Pharmaceutical Activated Carbon Sales by Region (2025-2030) & (M Units)

Table 15. Global Pharmaceutical Activated Carbon Sales Market Share by Region (2025-2030)

Table 16. Global Pharmaceutical Activated Carbon Production Value Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Pharmaceutical Activated Carbon Production Value by Region (2019-2024) & (US$ Million)

Table 18. Global Pharmaceutical Activated Carbon Production Value Market Share by Region (2019-2024)

Table 19. Global Pharmaceutical Activated Carbon Production Value by Region (2025-2030) & (US$ Million)

Table 20. Global Pharmaceutical Activated Carbon Production Value Market Share by Region (2025-2030)

Table 21. Global Pharmaceutical Activated Carbon Production Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Units)

Table 22. Global Pharmaceutical Activated Carbon Production by Region (2019-2024) & (M Units)

Table 23. Global Pharmaceutical Activated Carbon Production Market Share by Region (2019-2024)

Table 24. Global Pharmaceutical Activated Carbon Production by Region (2025-2030) & (M Units)

Table 25. Global Pharmaceutical Activated Carbon Production Market Share by Region (2025-2030)

Table 26. Global Pharmaceutical Activated Carbon Sales Quantity by Manufacturers (2019-2024) & (M Units)

Table 27. Global Pharmaceutical Activated Carbon Sales Quantity Share by Manufacturers (2019-2024)

Table 28. Global Pharmaceutical Activated Carbon Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 29. Global Pharmaceutical Activated Carbon Revenue Share by Manufacturers (2019-2024)

Table 30. Global Pharmaceutical Activated Carbon Price by Manufacturers 2019-2024 (US$/Unit)

Table 31. Global Key Players of Pharmaceutical Activated Carbon, Industry Ranking, 2022 VS 2023

Table 32. Global Pharmaceutical Activated Carbon Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 33. Global Pharmaceutical Activated Carbon by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Activated Carbon as of 2023)

Table 34. Global Key Manufacturers of Pharmaceutical Activated Carbon, Manufacturing Base Distribution and Headquarters

Table 35. Global Key Manufacturers of Pharmaceutical Activated Carbon, Product Offered and Application

Table 36. Global Key Manufacturers of Pharmaceutical Activated Carbon, Date of Enter into This Industry

Table 37. Mergers & Acquisitions, Expansion Plans

Table 38. Global Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2024) & (M Units)

Table 39. Global Pharmaceutical Activated Carbon Sales Quantity by Type (2025-2030) & (M Units)

Table 40. Global Pharmaceutical Activated Carbon Sales Quantity Share by Type (2019-2024)

Table 41. Global Pharmaceutical Activated Carbon Sales Quantity Share by Type (2025-2030)

Table 42. Global Pharmaceutical Activated Carbon Revenue by Type (2019-2024) & (US$ Million)

Table 43. Global Pharmaceutical Activated Carbon Revenue by Type (2025-2030) & (US$ Million)

Table 44. Global Pharmaceutical Activated Carbon Revenue Share by Type (2019-2024)

Table 45. Global Pharmaceutical Activated Carbon Revenue Share by Type (2025-2030)

Table 46. Pharmaceutical Activated Carbon Price by Type (2019-2024) & (US$/Unit)

Table 47. Global Pharmaceutical Activated Carbon Price Forecast by Type (2025-2030) & (US$/Unit)

Table 48. Global Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2024) & (M Units)

Table 49. Global Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2025-2030) & (M Units)

Table 50. Global Pharmaceutical Activated Carbon Sales Quantity Share by Distribution Channel (2019-2024)

Table 51. Global Pharmaceutical Activated Carbon Sales Quantity Share by Distribution Channel (2025-2030)

Table 52. Global Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 53. Global Pharmaceutical Activated Carbon Revenue by Distribution Channel (2025-2030) & (US$ Million)

Table 54. Global Pharmaceutical Activated Carbon Revenue Share by Distribution Channel (2019-2024)

Table 55. Global Pharmaceutical Activated Carbon Revenue Share by Distribution Channel (2025-2030)

Table 56. Pharmaceutical Activated Carbon Price by Distribution Channel (2019-2024) & (US$/Unit)

Table 57. Global Pharmaceutical Activated Carbon Price Forecast by Distribution Channel (2025-2030) & (US$/Unit)

Table 58. North America Pharmaceutical Activated Carbon Revenue by Company (2019-2024) & (US$ Million)

Table 59. North America Pharmaceutical Activated Carbon Sales Quantity by Company (2019-2024) & (M Units)

Table 60. North America Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2024) & (M Units)

Table 61. North America Pharmaceutical Activated Carbon Sales Quantity by Type (2025-2030) & (M Units)

Table 62. North America Pharmaceutical Activated Carbon Revenue by Type (2019-2024) & (US$ Million)

Table 63. North America Pharmaceutical Activated Carbon Revenue by Type (2025-2030) & (US$ Million)

Table 64. North America Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2024) & (M Units)

Table 65. North America Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2025-2030) & (M Units)

Table 66. North America Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 67. North America Pharmaceutical Activated Carbon Revenue by Distribution Channel (2025-2030) & (US$ Million)

Table 68. North America Pharmaceutical Activated Carbon Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. North America Pharmaceutical Activated Carbon Revenue by Country (2019-2024) & (US$ Million)

Table 70. North America Pharmaceutical Activated Carbon Revenue by Country (2025-2030) & (US$ Million)

Table 71. North America Pharmaceutical Activated Carbon Sales Quantity by Country (2019-2024) & (M Units)

Table 72. North America Pharmaceutical Activated Carbon Sales Quantity by Country (2025-2030) & (M Units)

Table 73. Europe Pharmaceutical Activated Carbon Sales Quantity by Company (2019-2024) & (M Units)

Table 74. Europe Pharmaceutical Activated Carbon Revenue by Company (2019-2024) & (US$ Million)

Table 75. Europe Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2024) & (M Units)

Table 76. Europe Pharmaceutical Activated Carbon Sales Quantity by Type (2025-2030) & (M Units)

Table 77. Europe Pharmaceutical Activated Carbon Revenue by Type (2019-2024) & (US$ Million)

Table 78. Europe Pharmaceutical Activated Carbon Revenue by Type (2025-2030) & (US$ Million)

Table 79. Europe Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2024) & (M Units)

Table 80. Europe Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2025-2030) & (M Units)

Table 81. Europe Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 82. Europe Pharmaceutical Activated Carbon Revenue by Distribution Channel (2025-2030) & (US$ Million)

Table 83. Europe Pharmaceutical Activated Carbon Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 84. Europe Pharmaceutical Activated Carbon Revenue by Country (2019-2024) & (US$ Million)

Table 85. Europe Pharmaceutical Activated Carbon Revenue by Country (2025-2030) & (US$ Million)

Table 86. Europe Pharmaceutical Activated Carbon Sales Quantity by Country (2019-2024) & (M Units)

Table 87. Europe Pharmaceutical Activated Carbon Sales Quantity by Country (2025-2030) & (M Units)

Table 88. China Pharmaceutical Activated Carbon Sales Quantity by Company (2019-2024) & (M Units)

Table 89. China Pharmaceutical Activated Carbon Revenue by Company (2019-2024) & (US$ Million)

Table 90. China Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2024) & (M Units)

Table 91. China Pharmaceutical Activated Carbon Sales Quantity by Type (2025-2030) & (M Units)

Table 92. China Pharmaceutical Activated Carbon Revenue by Type (2019-2024) & (US$ Million)

Table 93. China Pharmaceutical Activated Carbon Revenue by Type (2025-2030) & (US$ Million)

Table 94. China Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2024) & (M Units)

Table 95. China Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2025-2030) & (M Units)

Table 96. China Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 97. China Pharmaceutical Activated Carbon Revenue by Distribution Channel (2025-2030) & (US$ Million)

Table 98. APAC Pharmaceutical Activated Carbon Sales Quantity by Company (2019-2024) & (M Units)

Table 99. APAC Pharmaceutical Activated Carbon Revenue by Company (2019-2024) & (US$ Million)

Table 100. APAC Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2024) & (M Units)

Table 101. APAC Pharmaceutical Activated Carbon Sales Quantity by Type (2025-2030) & (M Units)

Table 102. APAC Pharmaceutical Activated Carbon Revenue by Type (2019-2024) & (US$ Million)

Table 103. APAC Pharmaceutical Activated Carbon Revenue by Type (2025-2030) & (US$ Million)

Table 104. APAC Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2024) & (M Units)

Table 105. APAC Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2025-2030) & (M Units)

Table 106. APAC Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 107. APAC Pharmaceutical Activated Carbon Revenue by Distribution Channel (2025-2030) & (US$ Million)

Table 108. APAC Pharmaceutical Activated Carbon Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 109. APAC Pharmaceutical Activated Carbon Revenue by Region (2019-2024) & (US$ Million)

Table 110. APAC Pharmaceutical Activated Carbon Revenue by Region (2025-2030) & (US$ Million)

Table 111. APAC Pharmaceutical Activated Carbon Sales Quantity by Region (2019-2024) & (M Units)

Table 112. APAC Pharmaceutical Activated Carbon Sales Quantity by Region (2025-2030) & (M Units)

Table 113. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Company (2019-2024) & (M Units)

Table 114. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Company (2019-2024) & (US$ Million)

Table 115. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Type (2019-2024) & (M Units)

Table 116. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Type (2025-2030) & (M Units)

Table 117. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Type (2019-2024) & (US$ Million)

Table 118. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Type (2025-2030) & (US$ Million)

Table 119. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2019-2024) & (M Units)

Table 120. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Distribution Channel (2025-2030) & (M Units)

Table 121. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Distribution Channel (2019-2024) & (US$ Million)

Table 122. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Distribution Channel (2025-2030) & (US$ Million)

Table 123. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 124. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Country (2019-2024) & (US$ Million)

Table 125. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue by Country (2025-2030) & (US$ Million)

Table 126. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Country (2019-2024) & (M Units)

Table 127. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity by Country (2025-2030) & (M Units)

Table 128. Jemincare Company Information

Table 129. Jemincare Description and Overview

Table 130. Jemincare Pharmaceutical Activated Carbon Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) & (US$/Unit) and Gross Margin (2019-2024)

Table 131. Jemincare Pharmaceutical Activated Carbon Products and Services

Table 132. Jemincare Pharmaceutical Activated Carbon SWOT Analysis

Table 133. Jemincare Recent Development

Table 134. Changtian Pharma Company Information

Table 135. Changtian Pharma Description and Overview

Table 136. Changtian Pharma Pharmaceutical Activated Carbon Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) & (US$/Unit) and Gross Margin (2019-2024)

Table 137. Changtian Pharma Pharmaceutical Activated Carbon Products and Services

Table 138. Changtian Pharma Pharmaceutical Activated Carbon SWOT Analysis

Table 139. Changtian Pharma Recent Development

Table 140. Kureha Company Information

Table 141. Kureha Description and Overview

Table 142. Kureha Pharmaceutical Activated Carbon Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) & (US$/Unit) and Gross Margin (2019-2024)

Table 143. Kureha Pharmaceutical Activated Carbon Products and Services

Table 144. Kureha Pharmaceutical Activated Carbon SWOT Analysis

Table 145. Kureha Recent Development

Table 146. Myvitamins Company Information

Table 147. Myvitamins Description and Overview

Table 148. Myvitamins Pharmaceutical Activated Carbon Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) & (US$/Unit) and Gross Margin (2019-2024)

Table 149. Myvitamins Pharmaceutical Activated Carbon Products and Services

Table 150. Myvitamins Pharmaceutical Activated Carbon SWOT Analysis

Table 151. Myvitamins Recent Development

Table 152. Key Raw Materials Lists

Table 153. Raw Materials Key Suppliers Lists

Table 154. Pharmaceutical Activated Carbon Distributors List

Table 155. Pharmaceutical Activated Carbon Customers List

Table 156. Pharmaceutical Activated Carbon Market Trends

Table 157. Pharmaceutical Activated Carbon Market Drivers

Table 158. Pharmaceutical Activated Carbon Market Challenges

Table 159. Pharmaceutical Activated Carbon Market Restraints

Table 160. Research Programs/Design for This Report

Table 161. Key Data Information from Secondary Sources

Table 162. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharmaceutical Activated Carbon Product Picture

Figure 2. Global Pharmaceutical Activated Carbon Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pharmaceutical Activated Carbon Market Share by Type in 2023 & 2030

Figure 4. Pharmaceutical Activated Carbon Capsule Product Picture

Figure 5. Pharmaceutical Activated Carbon Tablet Product Picture

Figure 6. Others Product Picture

Figure 7. Global Pharmaceutical Activated Carbon Market Size Growth Rate by Distribution Channel, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Pharmaceutical Activated Carbon Market Share by Distribution Channel in 2023 & 2030

Figure 9. Drug Stores

Figure 10. Prescription Drug

Figure 11. Pharmaceutical Activated Carbon Report Years Considered

Figure 12. Global Pharmaceutical Activated Carbon Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Pharmaceutical Activated Carbon Revenue 2019-2030 (US$ Million)

Figure 14. Global Pharmaceutical Activated Carbon Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Pharmaceutical Activated Carbon Sales Quantity 2019-2030 (M Units)

Figure 16. Global Pharmaceutical Activated Carbon Sales Quantity Market Share by Region (2019-2024)

Figure 17. Global Pharmaceutical Activated Carbon Sales Quantity Market Share by Region (2025-2030)

Figure 18. North America Pharmaceutical Activated Carbon Sales Quantity YoY (2019-2030) & (M Units)

Figure 19. North America Pharmaceutical Activated Carbon Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Pharmaceutical Activated Carbon Sales Quantity YoY (2019-2030) & (M Units)

Figure 21. Europe Pharmaceutical Activated Carbon Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Pharmaceutical Activated Carbon Sales Quantity YoY (2019-2030) & (M Units)

Figure 23. China Pharmaceutical Activated Carbon Revenue YoY (2019-2030) & (US$ Million)

Figure 24. APAC Pharmaceutical Activated Carbon Sales Quantity YoY (2019-2030) & (M Units)

Figure 25. APAC Pharmaceutical Activated Carbon Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity YoY (2019-2030) & (M Units)

Figure 27. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Global Pharmaceutical Activated Carbon Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 29. Global Pharmaceutical Activated Carbon Production Value Market Share by Region in Percentage: 2023 Versus 2030

Figure 30. Global Pharmaceutical Activated Carbon Capacity, Production and Utilization (2019-2030) & (M Units)

Figure 31. Global Pharmaceutical Activated Carbon Production by Region: 2019 VS 2023 VS 2030 (M Units)

Figure 32. Global Pharmaceutical Activated Carbon Production Market Share by Region in Percentage: 2023 Versus 2030

Figure 33. Pharmaceutical Activated Carbon Production Growth Rate in North America (2019-2030) & (M Units)

Figure 34. Pharmaceutical Activated Carbon Production Growth Rate in Europe (2019-2030) & (M Units)

Figure 35. Pharmaceutical Activated Carbon Production Growth Rate in Japan (2019-2030) & (M Units)

Figure 36. Pharmaceutical Activated Carbon Production Growth Rate in China (2019-2030) & (M Units)

Figure 37. Pharmaceutical Activated Carbon Production Growth Rate in South Korea (2019-2030) & (M Units)

Figure 38. Pharmaceutical Activated Carbon Production Growth Rate in India (2019-2030) & (M Units)

Figure 39. The Top 10 and Top 5 Players Market Share by Pharmaceutical Activated Carbon Sales Quantity in 2023

Figure 40. The Top 10 and Top 5 Players Market Share by Pharmaceutical Activated Carbon Revenue in 2023

Figure 41. Pharmaceutical Activated Carbon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 42. Global Pharmaceutical Activated Carbon Sales Quantity Market Share by Type (2019-2030)

Figure 43. Global Pharmaceutical Activated Carbon Revenue Market Share by Type (2019-2030)

Figure 44. Global Pharmaceutical Activated Carbon Sales Quantity Market Share by Distribution Channel (2019-2030)

Figure 45. Global Pharmaceutical Activated Carbon Revenue Market Share by Distribution Channel (2019-2030)

Figure 46. North America Pharmaceutical Activated Carbon Revenue Market Share by Company in 2023

Figure 47. North America Pharmaceutical Activated Carbon Sales Quantity Market Share by Company in 2023

Figure 48. North America Pharmaceutical Activated Carbon Sales Quantity Market Share by Type (2019-2030)

Figure 49. North America Pharmaceutical Activated Carbon Revenue Market Share by Type (2019-2030)

Figure 50. North America Pharmaceutical Activated Carbon Sales Quantity Market Share by Distribution Channel (2019-2030)

Figure 51. North America Pharmaceutical Activated Carbon Revenue Market Share by Distribution Channel (2019-2030)

Figure 52. North America Pharmaceutical Activated Carbon Revenue Share by Country (2019-2030)

Figure 53. North America Pharmaceutical Activated Carbon Sales Quantity Share by Country (2019-2030)

Figure 54. United States Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 55. Canada Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 56. Europe Pharmaceutical Activated Carbon Sales Quantity Market Share by Company in 2023

Figure 57. Europe Pharmaceutical Activated Carbon Revenue Market Share by Company in 2023

Figure 58. Europe Pharmaceutical Activated Carbon Sales Quantity Market Share by Type (2019-2030)

Figure 59. Europe Pharmaceutical Activated Carbon Revenue Market Share by Type (2019-2030)

Figure 60. Europe Pharmaceutical Activated Carbon Sales Quantity Market Share by Distribution Channel (2019-2030)

Figure 61. Europe Pharmaceutical Activated Carbon Revenue Market Share by Distribution Channel (2019-2030)

Figure 62. Europe Pharmaceutical Activated Carbon Revenue Share by Country (2019-2030)

Figure 63. Europe Pharmaceutical Activated Carbon Sales Quantity Share by Country (2019-2030)

Figure 64. Germany Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 65. France Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 66. U.K. Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 67. Italy Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 68. Russia Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 69. China Pharmaceutical Activated Carbon Sales Quantity Market Share by Company in 2023

Figure 70. China Pharmaceutical Activated Carbon Revenue Market Share by Company in 2023

Figure 71. China Pharmaceutical Activated Carbon Sales Quantity Market Share by Type (2019-2030)

Figure 72. China Pharmaceutical Activated Carbon Revenue Market Share by Type (2019-2030)

Figure 73. China Pharmaceutical Activated Carbon Sales Quantity Market Share by Distribution Channel (2019-2030)

Figure 74. China Pharmaceutical Activated Carbon Revenue Market Share by Distribution Channel (2019-2030)

Figure 75. APAC Pharmaceutical Activated Carbon Sales Quantity Market Share by Company in 2023

Figure 76. APAC Pharmaceutical Activated Carbon Revenue Market Share by Company in 2023

Figure 77. APAC Pharmaceutical Activated Carbon Sales Quantity Market Share by Type (2019-2030)

Figure 78. APAC Pharmaceutical Activated Carbon Revenue Market Share by Type (2019-2030)

Figure 79. APAC Pharmaceutical Activated Carbon Sales Quantity Market Share by Distribution Channel (2019-2030)

Figure 80. APAC Pharmaceutical Activated Carbon Revenue Market Share by Distribution Channel (2019-2030)

Figure 81. APAC Pharmaceutical Activated Carbon Revenue Share by Region (2019-2030)

Figure 82. APAC Pharmaceutical Activated Carbon Sales Quantity Share by Region (2019-2030)

Figure 83. Japan Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 84. South Korea Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 85. China Taiwan Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 86. Southeast Asia Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 87. India Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 88. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity Market Share by Company in 2023

Figure 89. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue Market Share by Company in 2023

Figure 90. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity Market Share by Type (2019-2030)

Figure 91. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue Market Share by Type (2019-2030)

Figure 92. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity Market Share by Distribution Channel (2019-2030)

Figure 93. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue Market Share by Distribution Channel (2019-2030)

Figure 94. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Sales Quantity Share by Country (2019-2030)

Figure 95. Middle East, Africa and Latin America Pharmaceutical Activated Carbon Revenue Share by Country (2019-2030)

Figure 96. Brazil Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 97. Mexico Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 98. Turkey Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 99. Israel Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 100. GCC Countries Pharmaceutical Activated Carbon Revenue (2019-2030) & (US$ Million)

Figure 101. Pharmaceutical Activated Carbon Value Chain

Figure 102. Pharmaceutical Activated Carbon Production Process

Figure 103. Channels of Distribution (Direct Vs Distribution)

Figure 104. Distributors Profiles

Figure 105. Bottom-up and Top-down Approaches for This Report

Figure 106. Data Triangulation

Figure 107. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharmaceutical Activated Carbon market? zhanKai

The top companies in the global Pharmaceutical Activated Carbon market are Jemincare、Changtian Pharma、Kureha.

Related Reports

Global Pharmaceutical Activated Carbon Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Activated Carbon market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 70
USD 4250.00
(Single User License)
Global Pharmaceutical Activated Carbon Market Research Report 2026
The global Pharmaceutical Activated Carbon market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-05
Pages: 119
USD 2900.00
(Single User License)
Pharmaceutical Activated Carbon- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-05
Pages: 86
USD 3950.00
(Single User License)
Global Pharmaceutical Activated Carbon Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Activated Carbon market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 72
USD 4250.00
(Single User License)
Global Pharmaceutical Activated Carbon Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 125
USD 4900.00
(Single User License)
Pharmaceutical Activated Carbon- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 86
USD 3950.00
(Single User License)
Global Pharmaceutical Activated Carbon Market Research Report 2025
The global market for Pharmaceutical Activated Carbon was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-19
Pages: 82
USD 2900.00
(Single User License)
Global Pharmaceutical Activated Carbon Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
The global Pharmaceutical Activated Carbon market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
Published Date: 2024-04-16
Pages: 132
USD 5900.00
(Single User License)
Global Pharmaceutical Activated Carbon Market Insights, Forecast to 2030
The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-07
Pages: 74
USD 4900.00
(Single User License)
Pharmaceutical Activated Carbon - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 81
USD 3950.00
(Single User License)

Global Pharmaceutical Activated Carbon Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Activated Carbon market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 70
USD 4250.00 (Single User License)
Global Pharmaceutical Activated Carbon Market Research Report 2026
The global Pharmaceutical Activated Carbon market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-05
Pages: 119
USD 2900.00 (Single User License)
Pharmaceutical Activated Carbon- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-05
Pages: 86
USD 3950.00 (Single User License)
Global Pharmaceutical Activated Carbon Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Activated Carbon market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 72
USD 4250.00 (Single User License)
Global Pharmaceutical Activated Carbon Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 125
USD 4900.00 (Single User License)
Pharmaceutical Activated Carbon- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 86
USD 3950.00 (Single User License)
Global Pharmaceutical Activated Carbon Market Research Report 2025
The global market for Pharmaceutical Activated Carbon was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-19
Pages: 82
USD 2900.00 (Single User License)
Global Pharmaceutical Activated Carbon Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
The global Pharmaceutical Activated Carbon market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
Published: 2024-04-16
Pages: 132
USD 5900.00 (Single User License)
Global Pharmaceutical Activated Carbon Market Insights, Forecast to 2030
The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-07
Pages: 74
USD 4900.00 (Single User License)
Pharmaceutical Activated Carbon - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 81
USD 3950.00 (Single User License)